External-use scald and burn drug capable of restraining keloid hyperplasia

Abstract

The invention discloses an external-use scald and burn drug capable of restraining keloid hyperplasia. The external-use scald and burn drug is characterized by being powder and being prepared from the following medicinal raw materials in parts by weight: 1-3 parts of mercury, 10-15 parts of sulfur, 15-20 parts of borax, 1-3 parts of borneol, 1-3 parts of musk, 20-30 parts of gypsum and 20-30 parts of calamine. A preparation method for the external-use scald and burn drug comprises the following steps: putting the sulfur, the mercury, the borax, the borneol, the calamine and sesame oil into a marmite in parts by weight; reversely buckling a seal cover by using a china bowl, heating after completely sealing junction of a porcelain bowl and the calamine through mud; after firstly heating for half an hour with strong fire and then heating for two hours with slow fire, naturally cooling to the room temperature, opening the calamine to scrape off medicinal raw materials coated in the porcelain bowl, adding an appropriate amount of musk into the medicinal raw materials to obtain a mixture, mixing and grinding the mixture into powder and passing the powder through a 100-mesh sieve, so as to prepare the external-use scald and burn drug capable of restraining keloid hyperplasia. The external-use scald and burn drug disclosed by the invention has effects of being quick in relieving pain, remarkable in curative effect and capable of restraining keloid hyperplasia, sterilizing, killing insects and inhibiting bacteria, and can be used for quickly restoring an injured cortical tissue and relieving pains of a patient.

Description

technical field [0001] The invention belongs to the technical field of medicines, in particular to a medicine for external use on scalds and burns for inhibiting the hyperplasia of scars. Background technique [0002] Burns are a common disease in life, and severe cases can affect life and work, causing serious physical and mental injuries to patients. According to reports, about 5% of scald patients in my country need hospital treatment, 95% of slightly injured patients can be treated at home and outpatient clinics, and 10% of hospitalized scald patients cause varying degrees of disability, causing irreversible damage to patients and families . Burns are mainly skin injuries caused by high-temperature liquids, high-temperature solids or high-temperature steam; burns are traumatic diseases caused by physical or chemical factors, such as heat, chemistry, electric current and radiation. The scars left after scalding and burns will affect the appearance or the physiological fu...

AI Technical Summary

Problems solved by technology

However, after searching, it was found that most of the commonly used medicines for treating scalds are based on traditional Chinese medicine ingredients. It is difficult to collect all the medicines in remote mountainous areas, which will delay the best treatment time, and even cause shock, infection and other diseases

Although the raw materials of very few drugs are easy to obtain, there are problems of poor curative effect and strong pain in patients

Patent No. 200910114987.9 discloses a medicine for burns and scalds and its preparation method. Although it solves the problem that it is difficult to collect complete medicinal materials in remote or poor areas, it uses quicklime as an

Images